TORL-1-23
TORL BioTherapeutics
['ovarian']
looks interesting private torl biotx announces initial results of novel claudin 6 (cldn6) adc torl-1-23 selected for presentation at #asco23 n=25 - mean 5 prior lot incl. 19 ovarian/3 testicular/3 endometrial cancers - 8 dls 0.2-2.4mg/kg iv q3w 
Biotellytics / https://t.co/37itIfRolp = business intel service on listed European Bios / Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design)